e-ISSN 1726-6890
p-ISSN 1735-0328
Citation data
CrossRef
Works that cite this article, indexed by Crossref.
7 resultsUpdated August 16, 2026
1
FGF-based drug discovery: advances and challenges
Nature Reviews Drug Discovery 24(5) (2025)
Gaozhi Chen; Lingfeng Chen; Xiaokun Li; Moosa Mohammadi
2
Current status and future perspectives of FGF21 analogues in clinical trials
Trends in Endocrinology & Metabolism 35(5) (2024)
Zara Siu Wa Chui; Qing Shen; Aimin Xu
3
Innovative Glucagon-based Therapies for Obesity
Journal of the Endocrine Society 8(12) (2024)
Kibret Enyew Belay; Rebil Heiru Jemal; Aloys Tuyizere
4
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Pharmacological Reviews 78(5) (2026)
Zara Siu Wa Chui; Yaqian Xue; Xiaoping Wu; Aimin Xu
6
Innovative approaches to the treatment of obesity: from pharmacotherapy to nanomedicine
Obesity and metabolism 21(4) (2024)
T. I. Romantsova
7
Novel triazole-based piperidine DPP-4 inhibitors with potent anti-diabetic activity: design, synthesis, and biological evaluation
Results in Chemistry 27 (2026)
Yasaman Pourbaba; Pegah Pourshaban; Ali Hashemi; Amir Garmabdari; Zahra Sheikholislam; Leila Bayat; Nima Naderi; Mohammad Mahboubi-Rabbani; Elham Rezaee; Sayyed Abbas Tabatabai